1. Introduction
   1. Market Introduction
   2. Market Research Methodology
      1. Research Process
      2. Primary Research
      3. Secondary Research     
      4. Data Collection Technique      
      5. Data Sources     
   3. Market Estimation Methodology
      1. Limitations of the Study
   4. Product Picture of Bile Duct Cancer
   5. Global Bile Duct Cancer: Classification
   6. Geographic Scope 
   7. Years Considered for the Study 
   8. Research Methodology in Brief  
   9. Parent Market Overview
   10. Overall Bile Duct Cancer Market Regional Demand
   11. Research Programs/Design       
   12. Market Breakdown and Data Triangulation Approach        
   13. Data Source
   14. Secondary Sources
   15. Primary Sources   
   16. Primary Interviews
   17. Average Primary Breakdown Ratio      
2. Market Dynamics
   1. Drivers
      1. Drivers
   2. Restraints
      1. Restraints
   3. Opportunity
      1. Impact forces on market dynamics  
      2. Impact forces during the forecast years     
   4. Industry Value Chain
      1. Upstream analysis       
      2. Downstream analysis   
      3. Distribution Channel    
      4. Direct Channel   
      5. Indirect Channel
   5. Potential Customers
   6. Manufacturing/Operational Cost Analysis
   7. Key Material Landscape
   8. Porter’s Analysis
      1. Supplier Power   
      2. Buyer Power
      3. Substitution Threat      
      4. Threat from New Entry 
      5. Competitive Rivalry      
   9. PESTEL Analysis 
      1. Political Factors  
      2. Economic Factor 
      3. Social Factors     
      4. Technological Factor     
      5. Environmental Factors 
      6. Legal Factor       
3. Global Bile Duct Cancer Market Segmentation, Revenue (USD Million), (2024-2031)
   1. By Type
      1. Intrahepatic Cholangiocarcinoma
      2. Extrahepatic Cholangiocarcinoma
      3. Distal Cholangiocarcinoma
   2. By Product Type
      1. Gemcitabine
      2. Cisplatin
      3. Oxaliplatin
      4. Capecitabine
      5. 5-fluorouracil (5-FU)
   3. By Treatment
      1. Chemotherapy
         1. Gemcitabine-Based Chemotherapy
         2. Cisplatin-Based Chemotherapy
      2. Radiation Therapy
      3. Surgery
         1. Liver Transplant
         2. Bile Duct Resection
      4. Targeted Therapy
         1. FGFR Inhibitors
         2. IDH1 Inhibitors
      5. Immunotherapy
         1. PD-1/PD-L1 Inhibitors
         2. CTLA-4 Inhibitors
      6. Others
   4. By Diagnosis
      1. Imaging Tests
         1. Ultrasound
         2. CT Scan
      2. MRI
      3. Biopsy
      4. Endoscopic Retrograde Cholangiopancreatography (ERCP)
      5. Blood Tests
   5. By End-User
      1. Hospitals
      2. Cancer Research Institutes
      3. Specialty Clinics
      4. Ambulatory Surgery Centers (ASCs)
      5. Others

4. Global Bile Duct Cancer Market Overview, By Region
   1.  North America Bile Duct Cancer Market Revenue (USD Million), By Countries, (2024-2031)
      1.  US
         1. By Type
         2. By Product Type
         3. By Treatment
         4. By Diagnosis
         5. By End-User
      2. Canada
      3. Mexico
   2. Europe Bile Duct Cancer Market Revenue (USD Million), By Countries, (2024-2031)
      1. Germany
      2. France        
      3. UK
      4. Spain
      5. Russia
      6. Italy
      7. BENELUX
   3. Asia Pacific Bile Duct Cancer Market Revenue (USD Million), By Countries, (2024-2031)
      1.  China
      2.  Japan
      3.  Australia
      4.  South Korea
      5.  India
      6.  ASEAN
   4. Latin America Bile Duct Cancer Market Revenue (USD Million), By Countries, (2024-2031)
      1.  Brazil
      2.  Argentina
      3.  Chile
   5. Middle East and Africa Bile Duct Cancer Market Revenue (USD Million), By Countries, (2024-2031)
      1. GCC
      2. Turkey        
      3. South Africa
5. Global Bile Duct Cancer Market Revenue: Competitive Analysis, 2023
   1. Key strategies By players
   2. Revenue (USD Million) and Market Share (%), By Manufacturers, 2023
   3. Player Positioning By Market Players, 2023
6. Competitive Analysis
   1. F. Hoffmann-La Roche AG (Switzerland)
      1. Business Overview
      2. Business Financials (USD Million)
      3. Product Category, Type, and Specification    
      4. Main Business/Business Overview
      5. Geographical Analysis
      6. Recent Development
      7. Swot Analysis
   2. Novartis AG (Switzerland)
   3. Merck and Co., Inc. (USA)
   4. Bristol-Myers Squibb (USA)
   5. Pfizer Inc. (USA)
   6. Lilly (USA)
   7. AstraZeneca (UK)
   8. Bayer AG (Germany)
   9. Sanofi (France)
   10. Johnson and Johnson Services, Inc. (USA)
7. Market Research Findings & Conclusion 

Disclaimer